UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000005843 |
|---|---|
| Receipt number | R000006906 |
| Scientific Title | A Multi-center Phase II Study evaluating efficacy and safety of Dasatinib in Patients with newly diagnosed Philadelphia(Ph) chromosome positive Chronic Myeloid Leukemia in chronic phase. |
| Date of disclosure of the study information | 2011/06/24 |
| Last modified on | 2023/01/04 20:33:31 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2011/06/24 12:57:55 | ||
| 2 | Update | 2012/02/03 15:42:46 | Email1 |
|
| 3 | Update | 2012/02/03 15:45:46 | Recruitment status |
|
| 4 | Update | 2023/01/04 20:33:31 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Address TEL Last name of contact person Last name of contact person Zip code Address Address TEL Name of primary person or sponsor Department Organization Organization Organization Address Address Tel |
